retatrutide weight loss trials results Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished Lost 50lbs in 3 months!

Side Effects Compared With Other GLP-1 Drugs The side effects reported in retatrutide trials are similar to those seen with other GLP-1-based drugs, but some studies suggest they may occur more frequently at higher doses

They are given by injections

Functional Benefits of the Weight Loss Support IV Assists in fatty acid oxidation and mitochondrial energy production Supports liver function and detoxification during active weight loss Helps restore B-vitamin and electrolyte balance May reduce fatigue, brain fog, or exercise burnout during calorie restriction Can enhance compliance and recovery within structured weight loss plans Complements medication-based protocols, including GLP-1 agonists Some patients using GLP-1 medications particularly in the early phases or during dose adjustments may experience reduced appetite to the point where maintaining adequate nutrient intake becomes difficult

doi: 10.1016/j.npep.2020.102110

What to do if your medication gets warm or cold Despite best efforts, temperature excursions happen

When Sulfur Burps Typically Occur Understanding the timeline helps you anticipate and prepare for this side effect